Oxford launches its first results from the COVID-19 vaccine trial

Interim results of Oxford University's Phase I/II trial of a COVID-19 vaccine were published today in the scientific journal, The Lancet. They indicate no safety concerns, as well as T-cell and antibody responses against the SARS-CoV-2 virus, and neutralising antibody response. The trials will continue, in order to find out whether these responses are the type and strength needed to fight the virus. Find out more about the vaccine: https://www.ox.ac.uk/covid-vaccine

Category